Scopus BioPharma Statistics
Total Valuation
SCPS has a market cap or net worth of $46,293. The enterprise value is -$315,804.
| Market Cap | 46,293 |
| Enterprise Value | -315,804 |
Important Dates
The last earnings date was Tuesday, August 29, 2023, before market open.
| Earnings Date | Aug 29, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
SCPS has 42.08 million shares outstanding. The number of shares has increased by 88.40% in one year.
| Shares Outstanding | 42.08M |
| Shares Change (YoY) | +88.40% |
| Shares Change (QoQ) | +30.86% |
| Owned by Insiders (%) | 18.69% |
| Owned by Institutions (%) | n/a |
| Float | 34.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.05
| Current Ratio | 0.05 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1,747.71% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$668,910 |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SCPS has paid $2.61 billion in taxes.
| Income Tax | 2.61B |
| Effective Tax Rate | 100.33% |
Stock Price Statistics
The stock price has decreased by -97.71% in the last 52 weeks. The beta is 1.01, so SCPS's price volatility has been similar to the market average.
| Beta (1Y) | 1.01 |
| 52-Week Price Change | -97.71% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 36.10 |
| Average Volume (30 Days) | 1,286 |
Short Selling Information
The latest short interest is 23,773, so 0.06% of the outstanding shares have been sold short.
| Short Interest | 23,773 |
| Short Previous Month | 38,430 |
| Short % of Shares Out | 0.06% |
| Short % of Float | 0.07% |
| Short Ratio (days to cover) | 0.22 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.62B |
| Pretax Income | -9.34M |
| Net Income | -8.70M |
| EBITDA | -9.34M |
| EBIT | -9.34M |
| Earnings Per Share (EPS) | -$0.32 |
Balance Sheet
The company has $362,097 in cash and no debt, giving a net cash position of $362,097 or $0.01 per share.
| Cash & Cash Equivalents | 362,097 |
| Total Debt | n/a |
| Net Cash | 362,097 |
| Net Cash Per Share | $0.01 |
| Equity / Book Value | -9.45M |
| Book Value Per Share | -0.22 |
| Working Capital | -10.51M |
Cash Flow
In the last 12 months, operating cash flow was -$3.04 million and capital expenditures -$1.55 million, giving a free cash flow of -$4.59 million.
| Operating Cash Flow | -3.04M |
| Capital Expenditures | -1.55M |
| Free Cash Flow | -4.59M |
| FCF Per Share | -$0.12 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SCPS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -88.40% |
| Shareholder Yield | -88.40% |
| Earnings Yield | -18,784.32% |
| FCF Yield | -9,921.75% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |